We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.3B
AUM Growth
-$128M
Cap. Flow
-$697M
Cap. Flow %
-6.16%
Top 10 Hldgs %
41.41%
Holding
1,243
New
52
Increased
320
Reduced
317
Closed
40

Top Buys

Rank Stock Value
1
HST icon
Host Hotels & Resorts
HST
+$98.9M
2
PSA icon
Public Storage
PSA
+$78.4M
3
MAC icon
Macerich
MAC
+$57.8M
4
VICI icon
VICI Properties
VICI
+$56M
5
EQR icon
Equity Residential
EQR
+$46.3M

Top Sells

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$144M
2
AMT icon
American Tower
AMT
+$112M
3
LSI
Life Storage, Inc.
LSI
+$105M
4
CUZ icon
Cousins Properties
CUZ
+$69.4M
5
DOC icon
Healthpeak Properties
DOC
+$67.5M

Sector Composition

Rank Sector Weight
1 Real Estate 72.31%
2 Technology 4.13%
3 Industrials 3.02%
4 Financials 2.93%
5 Healthcare 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INO icon
1151
Inovio Pharmaceuticals
INO
$79.8M
$1K ﹤0.01%
42
– –
KALA icon
1152
KALA BIO
KALA
$11.8M
– –
0
– –
KPTI icon
1153
PUT
Karyopharm Therapeutics
KPTI
$168M
$1K ﹤0.01%
+18
New +$1.45K
MCRB icon
1154
Seres Therapeutics
MCRB
$48M
$1K ﹤0.01%
11
– –
MNKD icon
1155
MannKind Corp
MNKD
$1.28B
$1K ﹤0.01%
1,042
– –
NERV icon
1156
Minerva Neurosciences
NERV
$188M
$1K ﹤0.01%
27
– –
NVAX icon
1157
Novavax
NVAX
$1.23B
$1K ﹤0.01%
+148
New +$1.17K
OCUL icon
1158
Ocular Therapeutix
OCUL
$1.86B
$1K ﹤0.01%
268
– –
STIM icon
1159
Neuronetics
STIM
$120M
$1K ﹤0.01%
112
– –
SYRE icon
1160
Spyre Therapeutics
SYRE
$8.87B
$1K ﹤0.01%
6
– –
TLPH icon
1161
Talphera
TLPH
$70.1M
$1K ﹤0.01%
25
– –
VSTM icon
1162
Verastem
VSTM
$532M
$1K ﹤0.01%
40
– –
EIGR
1163
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1K ﹤0.01%
4
– –
GOL
1164
PUT
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$1K ﹤0.01%
+71
New +$940
PRTK
1165
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1K ﹤0.01%
173
– –
SURF
1166
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
181
– –
KDNY
1167
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
85
– –
APTX
1168
DELISTED
Aptinyx Inc. Common Stock
APTX
$1K ﹤0.01%
350
– –
SIOX
1169
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
123
-1
-0.8% -$8
ADMS
1170
DELISTED
Adamas Pharmaceuticals
ADMS
$1K ﹤0.01%
142
– –
SBBP
1171
DELISTED
Strongbridge Biopharma plc.
SBBP
$1K ﹤0.01%
220
– –
FPRX
1172
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1K ﹤0.01%
160
– –
PETX
1173
DELISTED
Aratana Therapeutics, Inc.
PETX
$1K ﹤0.01%
238
– –
AA icon
1174
Alcoa
AA
$11.7B
– –
-13,280
Closed -$374K
ACRS icon
1175
Aclaris Therapeutics
ACRS
$730M
$0 ﹤0.01%
170
– –
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2019 Portfolio in Review

As of Q2 2019, Daiwa Securities Group held 1,243 positions worth $11.3B, down 1.1% from $11.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group withdrew a net $697M in Q2 2019, closing 40 positions and reducing 317 holdings. Its most notable exit was L3Harris, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 74% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Coupa Software Incorporated worth $4.17M.

  • Daiwa Securities Group's largest Q2 2019 buy was Coupa Software Incorporated: 32,900 shares worth $4.17M.
  • Daiwa Securities Group added most to Host Hotels & Resorts in Q2 2019, an estimated $98.9M increase.
  • Daiwa Securities Group's biggest Q2 2019 reduction was Digital Realty Trust, cutting an estimated $144M.
  • Daiwa Securities Group fully exited L3Harris in Q2 2019, selling an estimated $3.77M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11.3B portfolio in Q2 2019.
  • Daiwa Securities Group opened 52 new positions and closed 40 in Q2 2019.
  • Daiwa Securities Group's portfolio value fell 1.1% quarter-over-quarter to $11.3B.

Based on Daiwa Securities Group's 13F filing for Q2 2019, filed 24 Jul 2019.